PMID,Title,Journal,Year
34272645,Repurposing sodium-glucose co-transporter 2 inhibitors (SGLT2i) for cancer treatment - A Review.,Reviews in endocrine & metabolic disorders,2021
31979355,Dapagliflozin Inhibits Cell Adhesion to Collagen I and IV and Increases Ectodomain Proteolytic Cleavage of DDR1 by Increasing ADAM10 Activity.,"Molecules (Basel, Switzerland)",2020
31867105,SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia.,Cancer & metabolism,2019
31198610,Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient with Colon Malignancy.,Case reports in endocrinology,2019
29054804,Sodium Glucose Cotransporter 2 Inhibition Combined With Cetuximab Significantly Reduced Tumor Size and Carcinoembryonic Antigen Level in Colon Cancer Metastatic to Liver.,Clinical colorectal cancer,2018
27689018,The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration.,Molecular metabolism,2016
26522271,Effect of dapagliflozin on colon cancer cell [Rapid Communication].,Endocrine journal,2015
